Page 1590 - Small Animal Internal Medicine, 6th Edition

1562 Index

Hyperthyroidism (Continued) Hypoglossal nerve, 1056t, 1059–1060, Hypothyroidism (Continued) Immune-mediated disorders (Continued)
signalment of, 789 1060f endocrine alopecia caused by, 748t immunopathologic mechanisms,
signs of, 789, 790t Hypoglycemia, 806–809 etiology of, 767–768 leukopenia, 1248t
1211–1212, 1212t
VetBooks.ir systemic hypertension and, 791 clinical features of, 807 in puppies, 783 myasthenia gravis, 1250–1251, 1251t
peripheral vestibular disease caused
chronic, 852
surgery for, 798–799, 798b
by, 1115
myositis, 1252–1253, 1253b
diagnostic approach of, 807–808
T3 suppression test for, 793–794,
793f
iatrogenic, 806
thyroid scintigraphy, 794 etiology of, 806–807, 807b secondary, 767, 768b neutropenia, 1244–1245
tertiary, 767, 768b
pathogenesis of, 1211–1214
thyroidectomy for, 796t, 798, 798b insulin therapy and, 824, 837–838 Hypoxemia polyarthritis, 1119
thyrotoxic cardiomyopathy, 790 seizures caused by, 808b arterial, 113 breed-specific, 1245t
treatment of, 794–800 signs of, 807 cyanosis as sign of, 284 clinical features of, 1245–1246,
urinary tract infection with, 791 treatment of, 808–809, 808b, 815 1246b
chronic kidney disease, 696f, 698 Hypoglycemic drugs, 808b, 835–837 I cytologic findings, 1246, 1246f
myocardial hypertrophy and, 162 Hypogonadism, 754 Iatrogenic gastric outflow obstruction, diagnosis of, 1246, 1246f
Hypertonic enemas, 445 Hypokalemia, 47, 49b, 921–923, 922b, 467 erosive, 1208, 1245t
Hypertonic saline, 432–433, 934t 923t Iatrogenic hyperadrenocorticism, 858, etiology of, 1245
Hypertriglyceridemia, 909, 910t Hypokalemic polymyopathy, 1178–1179, 870 glucocorticoids for, 1203–1204,
Hypertrophic cardiomyopathy 1178f Iatrogenic hypoglycemia, 806 1204t, 1204b
in cats Hypokinetic, defined, 5 Iatrogenic hypoparathyroidism, 764 nonerosive, 1202–1204, 1202b,
breeds affected by, 158 Hypoluteiodism, 962–963 Ibutilide fumarate, 96 1204t, 1245t
clinical features of, 159–160 Hypomagnesemia, 844, 931–933, 932b Icteric mucous membranes, 5b, 1232f primary, 1245
clinicopathologic findings of, Hypomotility, idiopathic gastric, 469–470 Icterus, 525, 1232f signs of, 1246b
162–163 Hyponatremia, 74, 917–919, 918b Ictus, 1093 treatment of, 1246–1247
color flow Doppler imaging of, 164f Hypo-osmolality, 918 Idiopathic aplastic anemia, 1240 polymyositis, 1252–1253, 1253b
diagnosis of, 160, 161f, 163f Hypoparathyroidism, 798–799 Idiopathic canine chronic rhinitis, primary, 1211
echocardiographic findings of, iatrogenic, 764 268–269 pure red cell aplasia, 1238–1240, 1239t
160–163, 163f–164f primary, 763–766 Idiopathic chronic hepatitis, 586–595 secondary, 1211
electrocardiographic findings of, clinical signs of, 764, 764b Idiopathic epilepsy, 1094, 1105 treatment of, 1220–1230
160, 162f diagnosis of, 764–765 Idiopathic feline bronchitis, 329t azathioprine, 1223–1224
etiology of, 158 etiology of, 763–764 Idiopathic feline lower urinary tract chlorambucil, 1224, 1225t
myocardial ischemia secondary to, hypocalcemia caused by, 765t disease. see Feline idiopathic cystitis corticosteroids, 1222, 1222b
159 physical examination of, 764 Idiopathic gastric hypomotility, 469–470 cyclosporine, 1224–1226,
pathophysiology, 158–159 prognosis for, 766 Idiopathic interstitial pneumonias, 1225t–1226t
prevalence of, 159–160 signalment, 764 349–352 glucocorticoids, 1221–1223, 1222t
prognosis for, 167 treatment of, 765–766 Idiopathic megacolon, 507 human intravenous
radiographic findings of, 160, 161f transient, 764 Idiopathic preterm labor, 962–963, immunoglobulin, 1225t, 1228
treatment of, 163–164, 166b Hypophosphatemia, 843–844, 930–931, 963f–964f immunosuppressive therapy,
color flow Doppler of, 165f 930b Idiopathic pulmonary fibrosis, 329t, 1220–1221
description of, 80 Hypoproteinemia, 923 349–352, 350f leflunomide, 1225t, 1226–1227
in dogs, 152–153 Hyporexia, 407, 407b Idiopathic renal hematuria, 652, 652f mycophenolate mofetil, 1225t,
echocardiographic findings, 152 Hyposthenuria, 663, 742 Idiopathic thrombocytopenic purpura 1227–1228
subclinical, 163–164 Hypothalamic-pituitary-thyroid gland causes of, 1241t pentoxifylline, 1228–1229
Hyperventilation, 318, 1076 complex, 767, 768f classification of, 1240 principles of, 1220
Hyperviscosity Hypothalamus, disorders of, 740–757 clinical features of, 1240, 1242f splenectomy, 1228
description of, 113 Hypothyroid myopathy, 770–771 description of, 1216–1217 vincristine, 1225t, 1229
treatment of, 116 Hypothyroid polyneuropathy, 1164–1165 diagnosis of, 1240–1244 Immune-mediated hemolytic anemia
Hypoadrenocorticism, 654t–655t, Hypothyroidism etiology of, 1240 blood smear findings, 1234f
883–889 in cats, 785–788 feline, 1244 blood transfusion for, 1237
ACTH stimulation test for, 885–886 congenital, 788 immunosuppressive drugs for, 1243 bone marrow evaluation in, 1235
acute addisonian crisis, 886–888 diagnosis of, 786–787, 787f physical examination of, 1240, 1242f clinical features of, 1232
atypical, 884, 889 etiology of, 785–786 prognosis for, 1244 cytologic findings, 1232f
breeds at increased risk for, 884b levothyroxine for, 787 supportive care for, 1243–1244 definition of, 1231
clinical features of, 884–885 prognosis for, 788 treatment of, 1243 description of, 1348f, 1349–1351,
clinical pathology of, 884–885, 885b signs of, 786, 786f, 786b Idioventricular rhythm, accelerated, 1350f
definition of, 883 treatment of, 787 41 diagnosis of, 1215–1216, 1232–1235
diagnosis of, 885–886 congenital, 767–768 Ileocolic valve, 429f dog breeds at risk for, 1232b
electrocardiography for, 885 in dogs, 767–785 Ileoscopy, 428–429, 429f etiology of, 1231
etiology of, 883–884 autoimmune polyendocrine Ileus, anatomic, 419 genetic predisposition of, 1231
glucocorticoid-deficient, 889 syndromes associated with, 773 Imidapril, 64t glucocorticoids for, 1235–1236
imaging of, 885 behavioral problems associated Imidocloprid/moxidectin, 444t hemolysis prevention in, 1235–1237
megaesophagus and, 885 with, 772 Imipenem-cilastatin, 1437t–1438t history-taking, 1233b
physical examination of, 884 clinical features of, 768–773 Immiticide. see Melarsomine infectious diseases that cause, 1232b
primary, 886t clinical manifestations of, 770b dihydrochloride laboratory tests, 1232–1233, 1233b,
primary adrenal insufficiency, 888–889 clinical pathology of, 773–782 Immune-complex glomerulonephritis, 1234f, 1234t
secondary, 884, 886t congenital, 767–768 676–677, 676f myelofibrosis in, 1235
signalment for, 884 cretinism associated with, 772–773, Immune-mediated disorders nonregenerative, 1239t
signs of, 884, 884b 772b, 773f definition of, 1211 physical examination of, 1233b
treatment of, 886–889 dermatohistopathologic findings, dermatomyositis, 1253 prednisone for, 1350
Hypoalbuminemia 773–774 diagnostic approach to, 1215 prognosis for, 1237–1238
in canine monocytotropic ehrlichiosis, dermatologic signs of, 768–770, diagnostic tests, 1215–1219 regenerative, 1239t
1475 771f antinuclear antibody test, 1217 secondary, 1231, 1234, 1235t
in dogs, 923 diagnosis of, 782–783 antiplatelet antibodies, 1216–1218 spherocytes in, 1233, 1234t
nephrotic syndrome causing, 684 estrous cycle affected by, 956 autoimmune panels, 1218 supportive care for, 1237
plasma oncotic pressure decreases etiology of, 767–768, 768b Coombs test, 1216, 1216b thromboembolism prevention in, 1237
caused by, 362 glomerular filtration rate, 772 C-reactive protein, 1217–1218 thrombosis associated with, 223
pulmonary edema caused by, 358 histologic findings, 769f immunofluorescence, 1218 treatment of, 1235–1237
Hypoallergenic diets, 434b levothyroxine, 783–784, 783b–784b immunohistochemistry, 1218 vaccinations and, 1231
Hypocalcemia, 48, 49b, 765t, 927–929, myopathies associated with, 1178 lupus erythematosus test, 1217 Immune-mediated orchitis, 1003–1004,
928b myxedema coma, 772 rheumatoid factor, 1217 1004f
Hypochloremic-hypokalemic metabolic neuromuscular signs of, 770–771 slide agglutination test, 1215–1216 Immune-mediated thrombocytopenia
alkalosis, 465–466 prognosis for, 785 examples of, 1212–1213 causes of, 1241t
Hypochromasia, 1345t reproductive signs of, 771–772 glomerulonephritis, 676, 678b, classification of, 1240
Hypocobalaminemia, 640 therapeutic monitoring, 784, 785f 1249–1250 clinical features of, 1240, 1242f
Hypoechoic, defined, 19 thyroid-stimulating hormone, 782 hemolytic anemia. see Immune- description of, 1396–1397
Hypogastric nerve, 995 treatment of, 783–785, 783b mediated hemolytic anemia diagnosis of, 1240–1244, 1248t
Hypoglobulinemia, 1362–1363 ultrasonographic findings, 774, 774f idiopathic aplastic anemia, 1240 etiology of, 1240